china
Dependence on China for sales, manufacturing or supply, and the trade, policy and economic risks that come with it.
Exposure · 41 companies
AAPL Apple Inc.
Exposed“Beginning in Q2 2025, the U.S. announced new tariffs on imports from China mainland, India, Japan, South Korea, Taiwan, Vietnam, the EU and other locations; several countries imposed or threatened reciprocal measures.”
- Revenue$478.8BYoY +15.1%
- Net income$132.2BYoY +18.0%
- Revenue$109.4BYoY +16.4%
- Net income$29.8BYoY +27.1%
AMAT Applied Materials
Exposed“AMAT’s operations, customers, and suppliers are globally distributed, with particular exposure to China, Taiwan, and Korea.”
- Revenue$9.1BYoY +24.8%
- Net income$2.5BYoY +42.7%
AMZN Amazon
Exposed“China-based sellers contribute significant third-party seller services and advertising revenue, while China-based suppliers provide significant components and finished goods, increasing exposure to trade restrictions, tariffs, geopolitical events, and other China-related disruptions.”
- Revenue$716.9BYoY +12.4%
- Net income$77.7BYoY +31.1%
- Revenue$201.9BYoY +12.1%
- Net income$20.7BYoY −2.4%
- Revenue$10.2BYoY +65.1%
- Net income$2.0BYoY +63.3%
ATTO Attovia Therapeutics, Inc.
Exposed“WuXi AppTec was added to the 1260H List on June 8, 2026; the effect of BIOSECURE Act restrictions and grandfathering remained uncertain, and WuXi Biologics was not then on the list.”
BBTX Bambusa Therapeutics, Inc.
Exposed“Reliance on China-based providers, including WuXi Biologics, BioNTech Zhuhai and Tigermed, exposes development and supply to political, regulatory, trade, currency and IP risks.”
BLSM BlossomHill Therapeutics, Inc.
Exposed“APIs for BH-30643 and BH-30236 are made in China, although candidate drug product is not currently manufactured there; the company is pursuing alternative suppliers outside China.”
BRKR Bruker
Exposed“Delayed Chinese government stimulus for high-end medical and industrial research instrumentation constrained growth.”
- Revenue$3.4BYoY +2.1%
- Net income−$8.6Mvs $113.1M year ago
- Revenue$874.0MYoY +1.6%
- Net income−$111.8MYoY −87.6%
BRVE Braveheart Bio, Inc.
Exposed“U.S.–China tensions, trade restrictions, tariffs, sanctions, data rules and other policy changes could disrupt supply, trials or the Hengrui relationship.”
BSX Boston Scientific
Exposed“Other pressures included increased Electrophysiology competition and slower LAAC market growth affecting WATCHMAN procedures, as well as China volume-based procurement effects in Endoscopy and Urology.”
- Revenue$5.1BYoY +1.4%
- Net income$582.0MYoY −22.9%
CDNS Cadence Design Systems
Exposed“Cadence identifies U.S.–China tensions and Taiwan’s role in the technology supply chain as significant exposures.”
- Revenue$1.6BYoY +22.0%
- Net income$289.7MYoY +0.9%
CI Cigna Group
Exposed“Cigna’s 50% share of the China insurance joint venture’s supporting portfolio was approximately $21.9B, about 75% debt securities, 20% equities and 5% long-term deposits and policy loans;”
- Revenue$73.7BYoY +5.6%
- Net income$1.4BYoY −22.8%
CSCO Cisco
Exposed“Macroeconomic and geopolitical conditions—including inflation, tariffs and trade restrictions, monetary-policy uncertainty, government disruptions, conflicts, and China-Taiwan tensions—could constrain IT spending, disrupt supply, increase costs, intensify price competition, and create excess inventory or capacity.”
- Revenue$63.3BYoY +11.8%
- Net income$13.3BYoY +30.3%
- Revenue$18.5BYoY +24.4%
- Net income$4.6BYoY +59.2%
CTVA Corteva
Exposed“A material portion of crop-protection inputs comes directly or indirectly from China.”
- Revenue$2.5BYoY −6.1%
- Net income−$570.0MYoY −78.1%
EMR Emerson Electric
Exposed“Sales by geographic destination in 2026 were: the Americas, 52 percent; Asia, Middle East & Africa, 30 percent (China, 9 percent); and Europe, 18 percent .”
- Revenue$19.0BYoY +5.4%
- Net income$2.7BYoY +18.5%
- Revenue$4.9BYoY +7.0%
- Net income$718.0MYoY +22.5%
FOIL Londian Wason New Energy Tech Inc.
Exposed“Substantially all operations and revenue are generated in China, exposing FOIL to PRC economic, political, legal and regulatory changes.”
FSLR First Solar
Exposed“The company is realigning Series 6 production at international facilities amid low-priced Chinese competition in Europe, India’s restrictions on Southeast Asian products, regional oversupply and U.S. import tariffs.”
- Revenue$1.2BYoY −22.8%
- Net income$571.1MYoY +25.2%
GM General Motors
Exposed“Automotive China JVs, whose vehicle sales are not included in GM revenue, reported Q3 revenue of **$6.649B from $6.121B** and net income of **$0.141B from $0.144B**.”
- Revenue$50.0BYoY +2.9%
- Net income$3.3BYoY +151.3%
ISRG Intuitive Surgical
Exposed“In China, provincial limits on charges for robotic-assisted surgery have reduced procedure volumes and pressured instruments-and-accessories pricing.”
- Revenue$10.1BYoY +20.5%
- Net income$2.9BYoY +23.0%
- Revenue$3.0BYoY +21.7%
- Net income$522.8MYoY −25.8%
KEYS Keysight Technologies
Exposed“Tariff increases announced beginning in fiscal Q2 2025, including higher rates on China, and retaliatory measures have added uncertainty and may raise costs, disrupt supply chains, and reduce customer demand.”
- Revenue$1.8BYoY +36.5%
- Net income$397.0MYoY +107.9%
KLAC KLA Corporation
Exposed“China is a major source of revenue, although its share declined to 30% of FY2026 revenue, from 33% in FY2025 and 43% in FY2024; KLA expects it may decline further.”
- Revenue$13.6BYoY +11.7%
- Net income$4.8BYoY +18.9%
- Revenue$4.1BYoY +28.9%
- Net income$1.5BYoY +38.1%
LRCX Lam Research
Exposed“China accounted for **34% of FY2026 revenue, 34% in FY2025, and 42% in FY2024**.”
- Revenue$23.2BYoY +26.0%
- Net income$7.3BYoY +35.6%
- Revenue$8.2BYoY +54.4%
- Net income$2.8BYoY +75.5%
MPWR Monolithic Power Systems
Exposed“China and Taiwan together represented the majority of Q3 revenue.”
- Revenue$1.2BYoY +63.1%
- Net income$271.1MYoY +50.8%
- Revenue$65.0BYoY +1.3%
- Net income$18.3BYoY +6.6%
- Revenue$18.1BYoY +4.7%
- Net income$5.1BYoY −12.4%
MRVL Marvell Technology
Exposed“Shipments to China represented **42%** of Q2 revenue (**$1.1615B**) and **43%** of H1 (**$2.2194B**), compared with 29% (**$583.4M**) and 33% (**$1.2923B**) a year earlier.”
- Revenue$2.7BYoY +36.5%
- Net income$308.0MYoY +58.1%
MW Tailored Brands, Inc. / DE
Exposed“In FY2025, direct product sourcing was concentrated in Vietnam (24%), Indonesia (14%), Bangladesh (11%) and China (11%).”
NET Cloudflare
Exposed“In China, network services depend substantially on JD Cloud; losing the relationship could impair service utility and results.”
- Revenue$782.5MYoY +39.2%
- Net income−$34.1Mvs −$1.3M year ago
NKE Nike
Exposed“Greater China revenue declined 13% currency-neutral, with footwear units down 14% and digital sales down 29%.”
- Revenue$46.4BYoY +0.2%
- Net income$3.1BYoY −3.4%
- Revenue$11.2BYoY −4.3%
- Net income$712.0MYoY −2.1%
NVDA Nvidia
Exposed“As of the end of fiscal year 2026, we were effectively foreclosed from competing in China's data center computing/compute market, and our effective foreclosure from the China market helped our competitors build larger developer and customer ecosystems to challenge us worldwide.”
- Revenue$215.9BYoY +65.5%
- Net income$120.1BYoY +64.7%
- Revenue$96.2BYoY +105.9%
- Net income$59.7BYoY +125.9%
QCOM Qualcomm
Exposed“China, including Hong Kong, accounted for $18.079B (42%) of revenue, down from $20.340B (46%); these figures reflect customer/licensee headquarters, not necessarily end-device sales locations.”
- Revenue$43.1BYoY −2.6%
- Net income$13.6BYoY +145.9%
- Revenue$9.9BYoY −4.0%
- Net income$2.0BYoY −24.9%
SMCI Supermicro
Exposed“As a result of regulatory changes, we may be required to obtain licenses or other authorizations to continue supporting existing customers or to supply existing products to new customers in China, Eastern Europe, Southeast Asia, and elsewhere.”
- Revenue$39.1BYoY +77.8%
- Net income$2.2BYoY +112.7%
- Revenue$19.9Bvs $5.0B year ago
- Net income$1.6Bvs $168.3M year ago
SNOW Snowflake Inc.
Exposed“In China, local law requires use of a Chinese-owned operating partner that controls certain aspects of operations and acts as seller of record, adding cost and partner, regulatory and geopolitical risk.”
- Revenue$1.5BYoY +35.1%
- Net income−$191.7MYoY +35.7%
SYTN Syntiant Corp.
Exposed“Our two manufacturing facilities in Suzhou, China and Penang, Malaysia provide exclusive assembly and test operations for our sensor business, supporting high-volume production of our SiSonic MEMS microphones, vibration sensors, and AISonic audio DSP products.”
TEL TE Connectivity
Exposed“TE has 19 principal manufacturing sites in China, and approximately 25% of FY2026 net sales were to customers in China; U.S.–China tensions, tariffs, restrictions, regulatory changes, or local-law issues could affect operations and sales.”
- Revenue$19.9BYoY +15.2%
- Net income$3.3BYoY +76.6%
- Revenue$5.2BYoY +13.8%
- Net income$748.0MYoY +17.2%
TMO Thermo Fisher Scientific
Exposed“Growth across pharma and biotech, industrial and applied markets, and North America, Europe and Asia-Pacific was partly offset by lower revenue in China.”
- Revenue$44.6BYoY +3.9%
- Net income$6.7BYoY +5.8%
- Revenue$12.1BYoY +9.1%
- Net income$1.7BYoY +6.5%
TXN Texas Instruments
Exposed“China revenue increased from $1.019 billion; Germany accounted for 9% of revenue, down from 10%.”
- Revenue$6.1BYoY +27.7%
- Net income$2.4BYoY +77.8%
UUUU ENERGY FUELS INC
Exposed“REE demand is supported by magnets used in EVs, robotics, energy and defense, but markets and supply chains remain volatile and China-centered.”
- Revenue$29.2MYoY +64.8%
- Net income−$52.2Mvs −$16.7M year ago
VAT VARSAL TECH, INC.
Exposed“VAT depends on two third-party facilities in China for substantially all of its products, under exclusive custom-manufacturing arrangements.”
WDC Western Digital
Exposed“The filing highlights Middle East tensions and China’s restrictions on rare earth minerals and related materials important to semiconductor and hard-drive manufacturing.”
- Revenue$12.9BYoY +35.7%
- Net income$9.4Bvs $1.9B year ago
- Revenue$4.4BYoY +55.5%
- Net income$1.8BYoY +50.5%
WWB WINDWARD BIO GROUP AG
Exposed“PRC-related policy, geopolitical, export-control, sanctions, or data-transfer restrictions could disrupt access to data, technology, materials, manufacturing, or support.”
No companies have a recent 8-K matching these events.
No companies in the selected roles.